STAAR Surgical Co Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
STAAR Surgical Co (STAA) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of -$17.27 million for the 12-month period ending 2026-01-02, per its 10-K filed 2026-03-03.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2026-03-03
- STAAR Surgical Co effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2026 was -$17.27M.
- STAAR Surgical Co effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2024 was -$1.90M, a 126.87% decline from fiscal 2023.
- STAAR Surgical Co effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2023 was $7.08M, a 26.03% decline from fiscal 2022.
- STAAR Surgical Co effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2022 was $9.57M, a 45.51% increase from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month |
|---|---|
| 2026-01-02 | -$17.27M 10-K · filed 2026-03-03 |
| 2024-12-27 | -$1.90M 10-K · filed 2026-03-03 |
| 2023-12-29 | $7.08M 10-K · filed 2026-03-03 |
| 2022-12-30 | $9.57M 10-K · filed 2025-02-21 |
| 2021-12-31 | $6.57M 10-K · filed 2024-02-27 |
| 2021-01-01 | $1.74M 10-K · filed 2023-02-23 |
| 2020-01-03 | $2.73M 10-K · filed 2022-02-23 |
| 2018-12-28 | $1.39M 10-K · filed 2021-02-24 |
| 2017-12-29 | -$781.00K 10-K · filed 2020-02-26 |
| 2016-12-30 | -$4.23M 10-K · filed 2019-02-21 |
| 2016-01-01 | -$1.91M 10-K · filed 2018-02-28 |
| 2015-01-02 | -$2.94M 10-K · filed 2017-03-02 |
| 2014-01-03 | $379.00K 10-K · filed 2016-03-11 |
| 2012-12-28 | -$176.00K 10-K · filed 2015-03-13 |
| 2011-12-30 | $919.00K 10-K · filed 2014-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |